ctrl K

Watchlist Price Alert

InVivo Therapeutics Corp... (NVIV)

NASDAQ: NVIV · Real-Time Price · USD

0.32

-0.17 (-34.43%)

At close: Feb 12, 2024, 9:00 PM

InVivo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	16.35M	19.03M	19.49M	6.6M	16.66M	12.91M	21.46M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	11.58M
Long-Term Investments	150K	150K	110K	110K	n/a	n/a	n/a
Other Long-Term Assets	n/a	1.12M	1.23M	1.23M	1.15M	82K	343K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.25M	111K	163K	181K	465K	896K	812K
Total Current Assets	17.6M	19.14M	19.66M	6.78M	17.13M	13.81M	33.85M
Property-Plant & Equipment	1.07M	1.36M	1.01M	1.28M	100K	157K	510K
Goodwill & Intangibles	n/a	n/a	9K	26K	n/a	n/a	78K
Total Long-Term Assets	1.22M	2.63M	2.25M	2.54M	1.25M	239K	931K
Total Assets	18.82M	21.77M	21.91M	9.32M	18.38M	14.04M	34.78M
Account Payables	617K	605K	481K	942K	815K	988K	1.01M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	1.67M	2.1M
Short-Term Debt	396K	361K	327K	294K	100K	452K	423K
Other Current Liabilities	1.46M	1.65M	1.16M	1.43M	1.29M	1.67M	3.41M
Total Current Liabilities	2.47M	2.61M	1.97M	2.66M	2.21M	3.11M	4.85M
Long-Term Debt	553K	949K	693K	1.02M	n/a	400K	852K
Other Long-Term Liabilities	55K	94K	59K	59K	61K	423K	135K
Total Long-Term Liabilities	608K	1.04M	752K	1.08M	61K	823K	987K
Total Liabilities	3.08M	3.65M	2.72M	3.74M	2.27M	3.94M	5.83M
Total Debt	949K	1.31M	1.02M	1.31M	100K	852K	1.27M
Common Stock	3K	3K	3K	2K	1K	1K	1K
Retained Earnings	-248.62M	-238.13M	-228.23M	-219.16M	-207.33M	-183.91M	-157.01M
Comprehensive Income	264.37M	256.24M	247.42M	224.74M	n/a	-1.82M	-3.22M
Shareholders Equity	15.75M	18.11M	19.19M	5.58M	16.11M	10.11M	28.95M
Total Investments	150K	150K	110K	110K	n/a	n/a	11.58M